Cell Type- and Phase-Dependent Immune Checkpoint Targeting in Sepsis: TIM-3 as a Model for Precision Immunomodulation
- DOI
- 10.3390/pharmaceutics18101343
- Published
- 2026-10-21
- Container
- Pharmaceutics
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/pharmaceutics18101343,
title = {Cell Type- and Phase-Dependent Immune Checkpoint Targeting in Sepsis: TIM-3 as a Model for Precision Immunomodulation},
author = {Jialiu Luo and Peidong Zhang and Shuaipeng Gu and Zhiqiang Lin and Yuhao Wu and Zhao-Hui Tang},
year = {2026},
journal = {Pharmaceutics},
doi = {10.3390/pharmaceutics18101343},
url = {https://doi.org/10.3390/pharmaceutics18101343}
}RIS
TY - JOUR TI - Cell Type- and Phase-Dependent Immune Checkpoint Targeting in Sepsis: TIM-3 as a Model for Precision Immunomodulation AU - Jialiu Luo AU - Peidong Zhang AU - Shuaipeng Gu AU - Zhiqiang Lin AU - Yuhao Wu AU - Zhao-Hui Tang PY - 2026 JO - Pharmaceutics DO - 10.3390/pharmaceutics18101343 UR - https://doi.org/10.3390/pharmaceutics18101343 ER -
APA
Luo, J., Zhang, P., Gu, S., Lin, Z., Wu, Y., & Tang, Z. (2026). Cell Type- and Phase-Dependent Immune Checkpoint Targeting in Sepsis: TIM-3 as a Model for Precision Immunomodulation. Pharmaceutics. https://doi.org/10.3390/pharmaceutics18101343
Source records
- crossref · retrieved 2026-11-07T08:54:15.133Z